• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IkappaB-α的突变形式对5-氟尿嘧啶诱导的人涎腺转化细胞凋亡的影响。

Effect of a mutant form of IkappaB-alpha on 5-fluorouracil-induced apoptosis in transformed human salivary gland cells.

作者信息

Motegi K, Azuma M, Aota K, Yamashita T, Tamatani T, Harada K, Yoshida H, Sato M

机构信息

Department of Oral and Maxillofacial Surgery 2, Tokushima University School of Dentistry, 3 Kuramoto-cho, Tokushima 770-8504, Japan.

出版信息

Oral Oncol. 2001 Feb;37(2):185-92. doi: 10.1016/s1368-8375(00)00071-3.

DOI:10.1016/s1368-8375(00)00071-3
PMID:11167147
Abstract

Increasing evidence indicates that transcription factor NF-kappaB may play a role in cell survival, and that some chemotherapeutic agents activate NF-kappaB, while inhibition of NF-kappaB renders cells sensitive to these drugs. 5-Fluorouracil (5-FU) exerts its cytotoxic effect through the induction of apoptosis. However, it still remains uncertain whether 5-FU treatment in combination with the inhibition of NF-kappaB largely exerts an anti-proliferative effect on the growth of neoplastic human salivary gland cells. Thus, we investigated whether NF-kappaB suppression in transformed human salivary gland (NS-SV-AC) cells leads to a marked reduction in cell growth in response to 5-FU treatment. Our results demonstrated that under unstimulated conditions, the ability of cell growth in the super-repressor form of IkappaB-alpha (srIkappaB-alpha) cDNA-transfected cell clones (ACMT-6 and -7) was significantly lower than that in the empty vector-transfected cell clone (ACpRc-1). In addition, the growth inhibition caused by 5-FU was greatly enhanced in ACMT-6 and -7 as compared to ACpRc-1. Based on fractional inhibition analysis, this growth inhibition was due to an additive effect of both inhibitors. Electrophoretic mobility shift assay revealed that NF-kappaB activity in these cell clones was not affected by treatment with 5-FU. Accordingly, our data provide evidence that the combination of 5-FU and NF-kappaB suppression cooperatively functions in the growth inhibition of NS-SV-AC cells.

摘要

越来越多的证据表明,转录因子核因子-κB(NF-κB)可能在细胞存活中发挥作用,并且一些化疗药物可激活NF-κB,而抑制NF-κB会使细胞对这些药物敏感。5-氟尿嘧啶(5-FU)通过诱导细胞凋亡发挥其细胞毒性作用。然而,5-FU联合抑制NF-κB是否对人涎腺肿瘤细胞的生长产生显著的抗增殖作用仍不确定。因此,我们研究了在转化的人涎腺(NS-SV-AC)细胞中抑制NF-κB是否会导致对5-FU治疗的细胞生长显著减少。我们的结果表明,在未刺激条件下,转染IkappaB-α(srIkappaB-α)cDNA的细胞克隆(ACMT-6和-7)的超抑制形式的细胞生长能力明显低于空载体转染的细胞克隆(ACpRc-1)。此外,与ACpRc-1相比,ACMT-6和-7中5-FU引起的生长抑制大大增强。基于部分抑制分析,这种生长抑制是由于两种抑制剂的相加作用。电泳迁移率变动分析显示,这些细胞克隆中的NF-κB活性不受5-FU处理的影响。因此,我们的数据提供了证据,表明5-FU和NF-κB抑制的联合作用在NS-SV-AC细胞的生长抑制中协同发挥作用。

相似文献

1
Effect of a mutant form of IkappaB-alpha on 5-fluorouracil-induced apoptosis in transformed human salivary gland cells.IkappaB-α的突变形式对5-氟尿嘧啶诱导的人涎腺转化细胞凋亡的影响。
Oral Oncol. 2001 Feb;37(2):185-92. doi: 10.1016/s1368-8375(00)00071-3.
2
TGF-beta1 inhibits NF-kappaB activity through induction of IkappaB-alpha expression in human salivary gland cells: a possible mechanism of growth suppression by TGF-beta1.转化生长因子β1通过诱导人唾液腺细胞中IκB-α表达来抑制核因子κB活性:转化生长因子β1抑制生长的一种可能机制
Exp Cell Res. 1999 Jul 10;250(1):213-22. doi: 10.1006/excr.1999.4503.
3
5-Fluorouracil induces apoptosis through the suppression of NF-kappaB activity in human salivary gland cancer cells.5-氟尿嘧啶通过抑制人涎腺癌细胞中NF-κB活性诱导细胞凋亡。
Biochem Biophys Res Commun. 2000 Jul 14;273(3):1168-74. doi: 10.1006/bbrc.2000.3072.
4
Inhibition of NF-kappa B augments sensitivity to 5-fluorouracil/folinic acid in colon cancer.抑制核因子-κB可增强结肠癌对5-氟尿嘧啶/亚叶酸的敏感性。
J Surg Res. 2004 Aug;120(2):178-88. doi: 10.1016/j.jss.2003.11.023.
5
Suppression of tumor necrosis factor alpha-induced matrix metalloproteinase 9 production by the introduction of a super-repressor form of inhibitor of nuclear factor kappaBalpha complementary DNA into immortalized human salivary gland acinar cells. Prevention of the destruction of the acinar structure in Sjögren's syndrome salivary glands.通过将核因子κBα抑制剂互补DNA的超抑制形式导入永生化人唾液腺腺泡细胞来抑制肿瘤坏死因子α诱导的基质金属蛋白酶9的产生。预防干燥综合征唾液腺腺泡结构的破坏。
Arthritis Rheum. 2000 Aug;43(8):1756-67. doi: 10.1002/1529-0131(200008)43:8<1756::AID-ANR12>3.0.CO;2-H.
6
Enhanced radiosensitization and chemosensitization in NF-kappaB-suppressed human oral cancer cells via the inhibition of gamma-irradiation- and 5-FU-induced production of IL-6 and IL-8.通过抑制γ射线和5-氟尿嘧啶诱导的白细胞介素-6和白细胞介素-8的产生,增强NF-κB抑制的人口腔癌细胞的放射增敏和化学增敏作用。
Int J Cancer. 2004 Mar 1;108(6):912-21. doi: 10.1002/ijc.11640.
7
Stable inhibition of NF-kappa B in salivary gland cells does not enhance sensitivity to TNF-alpha-induced apoptosis due to upregulation of TRAF-1 expression.
Exp Cell Res. 2002 May 15;276(1):111-9. doi: 10.1006/excr.2002.5515.
8
p38 mitogen-activated protein kinase and nuclear factor-κB facilitate CD40-mediated salivary epithelial cell death.p38丝裂原活化蛋白激酶和核因子κB促进CD40介导的唾液腺上皮细胞死亡。
J Rheumatol. 2012 Jun;39(6):1256-64. doi: 10.3899/jrheum.110097. Epub 2012 Apr 15.
9
Role of cytokines in the destruction of acinar structure in Sjögren's syndrome salivary glands.细胞因子在干燥综合征唾液腺腺泡结构破坏中的作用。
Lab Invest. 1997 Sep;77(3):269-80.
10
Suppression of tumor necrosis factor alpha-induced matrix metalloproteinase 9 production in human salivary gland acinar cells by cepharanthine occurs via down-regulation of nuclear factor kappaB: a possible therapeutic agent for preventing the destruction of the acinar structure in the salivary glands of Sjögren's syndrome patients.千金藤素通过下调核因子κB抑制肿瘤坏死因子α诱导的人唾液腺腺泡细胞中基质金属蛋白酶9的产生:一种预防干燥综合征患者唾液腺腺泡结构破坏的潜在治疗药物。
Arthritis Rheum. 2002 Jun;46(6):1585-94. doi: 10.1002/art.10315.

引用本文的文献

1
A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303).硼替佐米诱导治疗后进展时加用多柔比星治疗头颈部复发性或转移性腺样囊性癌的Ⅱ期临床试验:东部肿瘤协作组(E1303)试验。
Cancer. 2011 Aug 1;117(15):3374-82. doi: 10.1002/cncr.25852. Epub 2011 Jan 18.